| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |